Introduction:Basic information about CAS 191729-45-0|Tenacissoside H, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Tenacissoside H |
|---|
| CAS Number | 191729-45-0 | Molecular Weight | 794.965 |
|---|
| Density | 1.3±0.1 g/cm3 | Boiling Point | 815.4±65.0 °C at 760 mmHg |
|---|
| Molecular Formula | C42H66O14 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 235.5±27.8 °C |
|---|
Names
| Name | 12-acetoxy-1-acetyl-8-((5-((3,5-dihydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-10a,12a-dimethyltetradecahydro-1H-cyclopenta[1,2]phenanthro[1,10a-b]oxiren-11-yl 2-methylbutanoate |
|---|
| Synonym | More Synonyms |
|---|
Tenacissoside H BiologicalActivity
| Description | Tenacissoside H is a Chinese medicine monomer extracted, isolated from Caulis Marsdeniae Tenacissimae.IC50 value:Target:In vitro: TDH significantly inhibited cells proliferation in a time-and-dose-dependent manner. TDH arrested the cell cycle in S phase and significantly inhibited PI3K and NF-κB mRNA expression, compared with blank controlled group (P < 0.05). [1]In vivo: TDH strongly inhibits tumor growth and volume. PCNA expression was significantly decreased after treatment of TDH. TDH downregulated proteins expression in PI3K/Akt-NF-κB transduction cascade (P < 0.05). [1] |
|---|
| Related Catalog | Signaling Pathways >>Others >>OthersNatural Products >>SteroidsResearch Areas >>Cancer |
|---|
| References | [1]. Jia YS, et al. Antitumor Activity of Tenacissoside H on Esophageal Cancer through Arresting Cell Cycle and Regulating PI3K/Akt-NF-κB Transduction Cascade. Evid Based Complement Alternat Med. 2015;2015:464937. |
|---|
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|
| Boiling Point | 815.4±65.0 °C at 760 mmHg |
|---|
| Molecular Formula | C42H66O14 |
|---|
| Molecular Weight | 794.965 |
|---|
| Flash Point | 235.5±27.8 °C |
|---|
| Exact Mass | 794.445251 |
|---|
| PSA | 178.04000 |
|---|
| LogP | 4.73 |
|---|
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
|---|
| Index of Refraction | 1.551 |
|---|
| InChIKey | HRSFCYYMBMDMOU-ZIAOJATMSA-N |
|---|
| SMILES | CCC(C)C(=O)OC1C2C3(C)CCC(OC4CC(OC)C(OC5OC(C)C(O)C(OC)C5O)C(C)O4)CC3CCC23OC32CCC(C(C)=O)C2(C)C1OC(C)=O |
|---|
Safety Information
| Safety Phrases | 24/25 |
|---|
| HS Code | 29389090 |
|---|
Synonyms
| (3β,5α,11α,12β,14β,17α)-12-Acetoxy-3-{[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-β-D-allopyranosyl)-3-O-methyl-β-D-arabino-hexopyranosyl]oxy}-20-oxo-8,14-epoxypregnan-11-yl 2-meth ylbutanoate |
| Butanoic acid, 2-methyl-, (3β,5α,11α,12β,14β,17α)-12-(acetyloxy)-3-[[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-β-D-allopyranosyl)-3-O-methyl-β-D-arabino-hexopyranosyl]oxy]-8,14-ep oxy-20-oxopregnan-11-yl ester |
| Tenacissoside H |